Enter your login e-mail to the account
Search
- Sekundární dyslipoproteinémie
MUDr. Michal Vrablík, PhD., doc. MUDr. Richard Češka, CSc.
(1/2004, Main topic ) - Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - Classification of dyslipoproteinaemias: Part II – Secondary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(6/2009, Topic of the year ) - Podľa medzinárodnej akademickej nadácie R3i prináša ACCORD Lipid novú nádej diabetikom 2. typu s aterogénnou dyslipidémiou
MUDr. Ľubomíra Fábryová, PhD.
(2/2010, Topic of the year ) - Laktózová intolerancia a jej diétne riešenia
doc. MUDr. Peter Minárik, PhD., MSc, prof. Ing. Jozef Golian, Dr., MUDr. Peter Chlebo, PhD.
(4/2018, Review articles ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - NOVÉ TRENDY V PREVENCII ATEROSKLERÓZY
(3/2007, Events ) - Comparison of efficacy and safety of atorvastatin in a dosage of 20 mg and 30 mg in general practitioners’ practice
MUDr. Martin Čaprnda, PhD., Mgr. Ján Farkašovský, PharmDr. Silvia Encingerová, Mgr. Oliver Tlčimuka
(5/2016, Original articles & case reports ) - The review of clinical and preclinical studies about the effects of Chlorella pyrenoidosa and young barley leaves on organism
doc. MUDr. Martin Péč, PhD., doc. MUDr. Renata Péčová, PhD., Doc. RNDr. Peter Kubatka, PhD.
(5/2015, Review articles ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Risk factors of atherosclerosis: lipids and their relation to atherosclerosis
MUDr. Branislav Vohnout, PhD., doc. MUDr. Katarína Rašlová, CSc.
(3/2009, Topic of the year ) - Physical exercise – mandatory part of complex dyslipidemia managment
prof. MUDr. Dušan Meško, PhD.
(7-8/2009, Topic of the year ) - DIABETIC DYSLIPIDAEMIA – IMPORTANT PART OF THE COMPLEX CARE FOR THE PATIENTS WITH DIABETES TYPE 2
MUDr. Ľubomíra Fábryová
(1/2005, Topic ) - Adiposopathic dyslipidaemia
MUDr. Ľubomíra Fábryová, PhD., MPH
(6/2021, Topic of the year ) - Calcium – bone and cardiovascular effects
MUDr. Mária Rašková, Ph.D.
(3/2015, Electronic attachment ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - BLOCKADE OF ENDOCANNABINOID EC1-RECEPTORS AND ITS EFFECT ON THE CARDIOMETABOLIC RISK
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - ALCOHOL AND DIABETES MELLITUS
MUDr. Jiří Mudra, doc. MUDr. Zdeněk Rušavý
(1/2005, Topic ) - POSSIBILITIES OF DIAGNOSIS AND TREATMENT OF LIPIDS DISORDERS IN AMBULANCE OF GENERAL PRACTITIONER
MUDr. Ľubomíra Fábryová
(6/2005, clearly ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - Hypolipidemic treatment and target values of lipids
MUDr. Ondřej Kyselák, prof. MUDr. Vladimír Soška, CSc.
(1/2019, Review articles ) - Dry skin care
MUDr. Katarína Soršáková Trnovská, PhD.
(1/2024, Interdisciplinary consilium ) - Ezetimibe in the treatment of hypercholesterolaemia
doc. MUDr. David Karásek, Ph.D.
(3/2020, Review articles ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Influence of natural flavonoids on parameters of oxidative stress in patients with erectile dysfunction
MUDr. Branislav Trebatický, PhD., RNDr. Zuzana Országhová, PhD., doc. Ing. Ingrid Žitňanová, PhD., prof. Ing. Zdeňka Ďuračková, PhD., doc. RNDr. Jana Muchová, PhD., MUDr. Ivona Wilšinská, MUDr. Michaela Mihaľová, prof. MUDr. Peter Bujdák, CSc.
(4/2020, Original articles & case reports ) - The role of diet therapy in complex treatment of dyslipoproteinemias
MUDr. Viera Kissová, PhD.
(9/2009, Topic of the year ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Effective drug therapy of liver diseases in general practice
doc. MUDr. Radan Brůha, CSc.
(1/2014, Review articles ) - Current prospects in life-style and pharmacological control of adipose tissue morphological and functional characteristics in obese patients
Mgr. Zuzana Janáková, MUDr. RNDr. Lukáš Varga, PhD., Doc. MUDr. Barbara Ukropcová, PhD., Mgr. Jozef Ukropec, DrSc.
(4/2017, Topic of the year ) - OBESITY AND TYPE 2 DIABETES (DIABESITY) – TWO CLOSELY RELATED, PREVENTABLE DISEASES IS THE THERAPY OF OBESITY TOOL FOR PREVENTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES?
MUDr. Ľubomíra Fábryová
(12/2006, Topic ) - Prediabetes
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mim. prof.
(1/2017, Review articles ) - TREATMENT OF ARRYTHMIA AND PHARMACOTHERAPY POSSIBILITIES
doc. MUDr. Peter Mitro, PhD.
(11/2007, Topic ) - Classification of dyslipoproteinaemias: Part I – Primary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(5/2009, Topic of the year ) - News in ESC/EAS recommendations 2019 for dyslipidemia management
MUDr. Ľubomíra Fábryová, PhD.
(6/2019, Review articles ) - Nutraceuticals in obesity management as part of cardiovascular rehabilitation
MUDr. Ivan Varga, PhD.
(5/2021, Review articles )
- Practical aspects and several new horizons for the use of ziprasidone
MUDr. Michal Patarák
(3/2013, Psychopharmacology ) - Ziprasidone treatment and metabolic parameters changes
MUDr. Jozef Dragašek, PhD., MUDr. Simona Líšková
(2/2011, Original articles & case reports ) - Enteral nutrition in gerontopsychiatry
MUDr. Miroslava Navrátilová
(3/2003, Review articles ) - Ziprasidone in the treatment of manic and mixed episodes of mild to moderate severity in patients with bipolar or schizoaffective disorder
MUDr. Dalibor Janoška, MUDr. Jozef Vido, MUDr. Petra Hermanová
(S1/2011, Original articles & case reports )
- Katogenic diet: its efficacy and practical use
MUDr. Ivana Tyrlíková, Pavel Klein, M.B., B. Chir.
(3/2015, Review articles ) - Neurologické projevy poruch metabolizmu lipidů
doc. MUDr. Ivanka Vlachová
(1/2005, Main topic ) - Epilepsy and metabolic syndrome X
MUDr. Irena Novotná
(3/2011, Review articles )
- Utilisation of omega fatty acids in pedopsychiatry
MUDr. Jana Trebatická, PhD., Mgr. Magdaléna Vaváková
(3/2015, Review articles ) - Risk factors of atherosclerosis in childhood
MUDr. Pavol Šimurka, PhD.
(5/2010, Review articles ) - The importance of PUFA omega-3 in children
doc. MUDr. Ludmila Vyhnánková, CSc.
(2/2011, Focus ) - Implications of human milk lipids and formula feeding in infants and children
prof. MUDr. Josef Sýkora, Ph.D.
(6/2021, Review articles ) - Seborrhoeic dermatitis
MUDr. Dušan Buchvald, PhD.
(3/2010, Review articles ) - LIPIDS IN CHILDHOOD NUTRITION
MUDr. Pavel Frühauf, CSc.
(1/2008, Review articles ) - Possibilities of affecting the immune system with nutraceutics
doc. MUDr. Pavel Kohout, Ph.D.
(6/2010, Review articles )
- Uncommon breast tumours – a pathologist´s view
doc. MUDr. Karol Kajo, PhD.
(1/2020, Review articles )
- Hormonal aging of skin
MUDr. Radek Litvik
(1/2009, Review articles ) - Impact of life style change to biochemical parameters in psoriasis patients
MUDr. Zuzana Rajczyová, Ing. Pavel Blažíček, CSc., prof. MUDr. Mária Šimaljaková, PhD., MHA
(1/2016, Original articles & case reports ) - Endocannabinoid system of the skin – novel findings and perspective therapeutic opportunities
doc. MUDr. Dušan Buchvald, CSc.
(1/2013, Review articles ) - Seborrhoeic dermatitis
MUDr. Dušan Buchvald, PhD.
(3/2009, Review articles ) - The use of zinc in dermatology
MUDr. Andrea Kozárová, PhD., MUDr. Marek Kozár, PhD.
(2/2022, Review articles ) - Dry skin care
MUDr. Katarína Soršáková Trnovská, PhD.
(4/2023, Topic of the year )
- HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes )
- The use of zinc in dermatology
MUDr. Andrea Kozárová, PhD., MUDr. Marek Kozár, PhD.
(2/2023, Current pharmacotherapy ) - Biological effects of Chlorella pyrenoidosa and young barley leaves with possible use in the prevention of civilization diseases
Doc. RNDr. Peter Kubatka, PhD.
(1/2018, Phytotherapy ) - Dry skin care
MUDr. Katarína Soršáková Trnovská, PhD.
(4/2023, Current pharmacotherapy ) - Almond oil in extemporaneous prescription
PharmDr. Jan Hašek
(3/2011, Pharmaceutical technology ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy )
- Markers of vulnerable plaque in atherosclerotic internal carotid artery affected
MUDr. Mária Kubíková, PhD., MUDr. Pavel Staško, PhD., MUDr. Peter Štefanič, MUDr. Peter Berek, PhD., MUDr. Ivan Kopolovets, MUDr. Jana Pobehová, PhD.
(1/2016, Main topic ) - Ruscus aculeatus– active compounds and healing effects
Mgr. Zdeňka Navrátilová
(1/2016, Drugs & drug classes )